Similar drugsTo uncover
Dosage form: & nbspGel for external use
Composition:

1 g of gel for external use contains:

active substances: β-Escin amorphous - 10,000 mg, sodium heparin (100 IU) - 0.714 mg; Excipients: Dexpanthenol 5,000 mg, allantoin powder 3,000 mg, sodium methylparahydroxybenzoate -3,000 mg, sodium hydroxide -3,700 mg, carboxypolymethylparagienic carbopol 934 P 12,500 mg, simethicone emulsion 2,000 mg, propylene glycol 50,000 mg, purified water up to 1,000 mg.

Description:Colorless or slightly opalescent transparent homogeneous gel.
Pharmacotherapeutic group:Venotonizing agent + anticoagulant direct for topical application
ATX: & nbsp
  • Heparin in combination with other drugs
  • Pharmacodynamics:

    Eszin is found in the seeds of horse chestnut (Aesculus hippocastanum L., semen). It is a mixture of triterpene saponins. Eszin has an anti-inflammatory effect mainly in the initial phase of the inflammatory reaction, "sealing" the walls of the capillaries and thus reducing their permeability, increased with inflammation. Eszin also has a positive effect on the fragility of the walls of the capillaries and increases the tone of the venous walls when it is weakened. All this leads to a reduction in stagnation in the venous bed and accumulation of fluid in the tissues, preventing the appearance of edema.

    Heparin prevents blood clotting and, thus, thrombosis of blood vessels, and also has an anti-inflammatory effect.

    Dexpanthenol and allantoin improve the absorption of both drugs through the skin and, thus, enhance their therapeutic effect.

    Indications:

    - subjective symptoms of chronic venous disease (pain and heaviness in the legs, night cramps in the calf muscles, skin itching, swelling of the legs);

    - phlebeurysm;

    - trauma (bruises, swelling of soft tissues, posttraumatic hematomas, sprain);

    - Thrombophlebitis of superficial veins;

    postinjection / postinfusion phlebitis;

    postthrombotic disease.

    Contraindications:

    - hypersensitivity to any of the components of the drug;

    - violation of the integrity of the skin (for example, with burns, eczema or open wounds);

    - children's age till 12 years;

    - Pregnancy;

    - the period of breastfeeding.

    Pregnancy and lactation:Controlled studies of the use of this drug during pregnancy and during breastfeeding were not conducted. Therefore, the Venitan® forte gel should not be used during pregnancy or during breastfeeding.
    Dosing and Administration:

    Outwardly.

    A thin layer of Venitan® forte gel should be applied to the skin of the painful areas and around them and gently rubbed. The gel should be applied 1-3 times a day. With inflammatory diseases the veins do not rub the gel. Do not immediately apply all the necessary amount of gel to the reception, it is applied gradually, in small portions.

    With trophic ulcers of the lower leg, gel should be applied to the edge of the ulcer, where blood circulation is disturbed; care should be taken so that the gel does not get directly to the surface of the ulcer.

    With varicose veins of the lower extremities, it is also recommended to use an elastic bandage or wear special tightening tights.

    Side effects:

    According to the World Health Organization (WHO), adverse reactions are classified according to their developmental frequency as follows: very often (≥1/10), often (from ≥1 / 100 to <1/10), infrequently (from ≥1 / 1000 to <1/100), rarely (from ≥1 / 10000 to <1/1000), very rarely (<1/10000); frequency is unknown - according to available data, it was not possible to establish the frequency of occurrence.

    From the skin and subcutaneous tissues

    rarely: allergic dermatitis (skin itching, redness of the skin, rashes on the skin), burning sensation.

    If hypersensitivity reactions develop, discontinue treatment immediately and consult a doctor.

    Overdose:Data on the overdose of the drug Venitan® forte are absent.
    Interaction:Do not apply other medications for external use to painful areas of the skin at the same time as Venitan® Forte.
    Special instructions:

    Avoid contact with eyes and mucous membranes. Wash hands thoroughly after using gel.

    The use of the Venitan® forte gel does not replace the other preventive and therapeutic measures (wearing special compression underwear, dousing with cold water). If inflammation occurs, subcutaneous seals, severe soreness, ulcers, sharp edema of one or both lower extremities, the appearance of symptoms of cardiac or renal insufficiency should immediately consult a doctor.

    Effect on the ability to drive transp. cf. and fur:The drug has no effect on the ability to perform potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms).
    Form release / dosage:Gel for external use.
    Packaging:

    50 g of gel in an aluminum tube covered with an aluminum membrane and a screw cap of low density polyethylene with a tip for puncturing the membrane.

    One tube with instructions for use is put in a cardboard box (the instruction is printed on paper with watermarks in the form of a logo of the holder of the registration certificate).

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-003833/08
    Date of registration:19.05.2008 / 26.08.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:Sandoz d.Sandoz d. Slovenia
    Manufacturer: & nbsp
    Representation: & nbspSANDOZ SANDOZ Switzerland
    Information update date: & nbsp25.01.2017
    Illustrated instructions
      Instructions
      Up